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• Thiazide diuretics and angiotensin II receptor blockers (ARB) are common medications for hypertension and 
are widely used together to counteract thiazide-induced hypokalemia
• Thiazide-associated hyponatremia (TAH) is fairly common. There are also multiple case series in the literature 
of severe hyponatremia in elderly pts attributed to initiation of a thiazide-ARB combination, even when the 
thiazide dose was low.  This is a unique case of hyponatremia in which ARB on thiazide therapy seems to 
have precipitated severe hyponatremia. 
• Given the temporal correlation of initiating irbesartan therapy to her symptoms, 
previously normal sodium levels on chlorthalidone alone, improvement with isotonic 
saline, resolution of hyponatremia with discontinuation of these medications, and no 
evidence of other underlying etiology, her severe hyponatremia was attributed to the 
addition of the ARB to her thiazide diuretic.  
• Thiazides reduce plasma volume and therefore blood pressure through inhibiting 
sodium reabsorption in the distal convoluted tubules.  ARBs inhibit the 
vasoconstriction and aldosterone-secreting effects of angiotensin II, similarly leading 
to renal sodium loss by decreased sodium reabsorption in the distal tubules and 
collecting ducts. 
• This is a 74-year-old female with a history of essential hypertension with intolerance to several 
antihypertensive medications, post-operative hyponatremia after laminectomy for cervical stenosis, mild 






• Cases of severe hyponatremia can occur with thiazides alone, but can be further 
promoted in combination with ARBs. Pts of advanced age and female sex seem at 
highest risk
• Early recognition through routine or symptom-onset lab monitoring can lead to 
timely drug discontinuation and medical management as needed to prevent 
serious complications
•Previously on combined HCTZ 25mg + telmisartan with improved BP but pt
stopped telmisartan due to cough (also had cough with ACE inhibitor and 
carvedilol)
•Severe hyponatremia s/p cervical laminectomy thought due diuretics and poor 
PO intake leading up to surgery
•Stopped chlorthalidone 25mg and spironolactone 25mg
•Continued amlodipine 5mg and started low dose metoprolol
•Chlorthalidone resumed a month later for refractory HTN, repeat BMP normal





•Max amlodipine was not effective and caused increased leg swelling   started 
irbesartan 75mg, amlodipine decreased, and chorthalidone 25mg continued
•Day 1 of ARB  developed lightheadedness/weakness, nausea, head fullness
•Day 3  stopped taking irbesartan but symptoms persisted
•Day 7  pt seen in clinic, labs showed Na 113 mmol/L referred for admission
Adding ARB to 
Thiazide 
Therapy
•Low serum osmolality of 238 mOsm/kg, high urine osmolality of 427 mOsm/kg, 
and high urine sodium of 64 mmol/L in the setting of recent diuretic therapy 
was consistent with hypotonic hypovolemic hyponatremia
•TSH wnl, low renin 1.5 ng/ml/hr
•Hyponatremia resolved with holding chlorthalidone and irbesartan, cautious 




•Pt was hesitant to re-trial irbesartan with close monitoring
•BP controlled on aliskiren 150mg daily, amlodipine 5mg BID; Na/BMP stableMonths Later …
• TAH has been reported in up to 30% of hospitalized pts. Proportions meta-analysis 
of 52 case series and 49 case reports of TAH pts showed risk factors include: 
-older age (mean age=75)
-female sex (79% of pts)
-possibly genetic susceptibility involving prostaglandin 
transporters (causing increased ADH activity)
• HCTZ was by far the most frequently implicated, either alone or with amiloride
(~70% of cases), followed by bendroflumethiazide, indapamide, HCTZ-
triamterene, chlorthalidone, and HCTZ-losartan (though there was high level of 
heterogeneity between studies)
• There are multiple case series in the literature of severe hyponatremia in elderly 
pts attributed to thiazide-ARB combination even though the thiazide dose was low.  
• In this case, the pt had tolerated higher dose chlorthalidone well until the addition 
of irbesartan. Literature review did not reveal any similar cases of ARB initiation on 
ongoing thiazide therapy that precipitated hyponatremia
• Literature review did not reveal reveal data stratifying risk of hyponatremia 
between different ARBs
• A possible mechanism includes lower renin and aldosterone activity and reduced 
renal response to aldosterone in the elderly compared to younger patients, on top 
of their susceptibility to TAH as above
CONCLUSION
